DOCSLIB.ORG

Apolipoprotein E and Low-Density Lipoprotein Receptor Gene Polymorphisms in Dyslipidemias-Associated Essential Hypertension

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Apolipoprotein E and Low-Density Lipoprotein Receptor Gene Polymorphisms in Dyslipidemias-Associated Essential Hypertension Journal of Human Hypertension (2007) 21, 337–339 & 2007 Nature Publishing Group All rights reserved 0950-9240/07 $30.00 www.nature.com/jhh RESEARCH LETTER Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension Journal of Human Hypertension (2007) 21, 337–339. (DBP)X90 mm Hg; (3) free of secondary causes of doi:10.1038/sj.jhh.1002151; published online 18 January 2007 hypertension through extensive biochemical and clinical examination; (4) without pharmacological treatment for hypertension. The BP of all 236 Hypertension has been strongly linked to a variety normotensives (131 male subjects/105 female sub- of lipoprotein metabolic abnormalities. Polymorph- jects) was below 140/90 mm Hg; all normotensives isms in the genes encoding the lipoproteins matched hypertensives for area, gender and age involved in metabolic abnormalities are the major without familial hypertension history, hepatic dis- target for evaluating the predisposition to the ease, renal insufficiency and diabetes. This study development of hypertension. In this study, two was approved by the Ethics Committee of Chinese candidate genes including apolipoprotein E (ApoE) Academy of Medical Sciences/Peking Union Medi- and low-density lipoprotein receptor (LDLR) were cal College and informed consent was obtained from selected to examine their possible contribution to each subject. hypertension in a Chinese Han population. Blood samples were drawn for DNA extraction Hypertension is a complex multifactorial and and biochemical examination. Genomic DNA was polygenic disorder that is thought to result from an extracted from white blood cells. Plasma TC, TG and interaction between an individual’s genetic makeup high-density lipoprotein cholestrol (HDLC) concen- and various environmental factors.1 Given that trations were determined enzymatically using com- hypertension is a major risk factor for cardiovascular mercially available kits and auto analyzer, and LDLC diseases, stroke and end-stage renal disease and was estimated using Friedewald’s formula. prevails globally, prevention of hypertension is an Two common polymorphisms including ApoE important public health goal.2 Onepreventiveap- e2/e3/e4 (rs7412/429358) and LDLR C1773T (rs688) proach is to identify disease-susceptibility genes that were selected based on physiological, biochemical involve a specific physiological or cellular function. and genetic studies reported previously. They are There is growing awareness that patients with involved in the regulation of lipoprotein metabo- hypertension tend to have a high prevalence of lism. The amplification of ApoE e2/e3/e4 poly- associated dyslipidemias such as the elevated total morphism was performed with the primers 50-AAC cholesterol (TC) and triglycerides (TG), and reduced AAC TGA CCC CGG TGG CG-30 (sense) and 50-ATG low-density lipoprotein cholesterol (LDLC).3 How- GCG CTG AGG CCG CGC TC-30 (antisense). Poly- ever, the exact mechanism leading to these dyslipi- merase chain reaction (PCR) reactions began with an demias remains unknown. It is reasonable to expect initial denaturation at 941C (5 min), then 30 cycles of that multiple genetic and/or physiological safe- 941C (45 s), 651C (45 s) and 721C (45 s), followed by a guards have developed to maintain lipoprotein final extension at 721C (5 min). PCR products were levels within a range of physiologically acceptable restricted with HhaI (Promega, Beijing, China), and levels. To address this issue, we performed an separated on 8% polyacrylamide gels. The C1773T association study for two lipoprotein-related gene polymorphism of LDLR was genotyped according to polymorphisms and hypertension. Our aim was to the previous report.4 evaluate the relationship of these polymorphisms Statistical calculations were performed using SAS with hypertension, as well as blood pressure and 9.1.3 (Institute Inc., Cary, NC, USA). Hardy–Weinberg plasma lipoprotein profiles, both solely and com- (H–W) equilibrium was tested using w2 test. Compar- bined in a Chinese population. isons among different means were calculated using All subjects in this study were of Han Chinese ANOVA. The association between polymorphisms currently residing in Shijiazhuang city. A total of and hypertension was analysed by logistic regression; 269 hypertensives (153 male subjects/116 female odds ratio (OR), and 95% confidence interval were subjects) met the following criteria: (1) onset of calculated. Data were expressed as mean7s.d.; all hypertension before age 65 years; (2) systolic P-values were two-sided; Po0.05 was considered blood pressure (SBP)X140 mm Hg or diastolic BP statistically significant. Research Letter 338 Table 1 The allele and genotype distributions of ApoE and LDLR in both groups and the comparisons of blood pressure and plasma lipoprotein profiles among different genotypes both solely and combined in hypertensives Genotype counts (n) Allele counts (n) ApoE E2/2 E2/3 E2/4 E3/3 E3/4 E4/4 P e2 e3 e4P Hypertensives 12 80 48 73 52 4 152 278 108 Normotensives 15 118 9 77 16 1 o0.0001w 157 288 27 0.0006z LDLR CC CT TT P CT P Hypertensives 100 96 73 296 242 Normotensives 127 85 24 o0.0001z 339 133 o0.0001 Hypertensives ApoE genotypes LDLR genotypes E2/2+E2/3 E3/3 E3/4+E4/4 CC CT TT BMI (kg/m2) 25.872.6 26.072.4 25.972.7 25.972.3 25.772.2 26.172.4 SBP (mm Hg) 160.6718.1 161.9717.9 161.7714.9 160.6716.9 161.5718.1 162.3715.6 DBP (mm Hg) 97.2710.5 98.5711.7 98.6710.7 96.0711.8 99.4711.4 100.0716.9* TC (mmol/l) 1.770.8 1.770.7 1.671.0 1.670.7 1.670.8 1.771.5 TG (mmol/l) 4.871.0 5.070.8 5.371.0* 4.971.0 4.970.9 5.471.1* LDLC (mmol/l) 3.070.8 3.270.7 3.670.9* 3.170.8 3.270.7 3.570.6* HDLC (mmol/l) 1.571.0 1.470.3 1.370.3 1.770.4 1.571.0 1.370.3* Hypertensives Genotype combinations ApoE-LDLR E2/2+E2/3–CC E2/2+E2/3–TT E3/3–CC E3/3–TT E3/4+E4/4–CC E3/4+E4/4–TT BMI (kg/m2) 25.772.6 25.972.5 26.172.2 25.772.6 26.270.2 26.072.8 SBP (mmHg) 162.5714.4 159.279.9 160.0718.4 159.0720.4 161.8710.3 159.6716.6 DBP (mmHg) 100.7710.2 99.776.1 101.4712.1 97.074.5 98.0710..8 99.2710.3 TC (mmol/l) 1.670.7 1.870.6 1.770.8 1.670.8 1.670.9 1.771.0 (TG (mmol/l) 4.871.1 4.870.9 4.970.7 5.170.3 5.370.7 5.571.1** LDLC (mmol/l) 3.170.9 3.170.4 3.170.8 3.270.4 3.570.7 3.470.9** HDLC (mmol/l) 1.570.3 1.670.3 1.370.3 1.670.2 1.270.1 1.370.4* Abbreviations: ApoE, apolipoprotein E; BMI, body mass index; DBP, diastolic blood pressure; HDLC, high-density lipoprotein cholestrol; LDLR; low-density lipoprotein receptor, SBP, systolic blood pressure; TC, total cholestrol; TG, total cholestrol. Data are expressed as mean7s.d. wP was calculated by w2 test 6 Â 2 contingency table degree of freedom (df) ¼ 5; zP was calculated by w2 test 3 Â 2 contingency table (df ¼ 2); P was calculated by w2 test 2 Â 2 contingency table (df) ¼ 1. *denotes statistical difference (Po0.05) among different means using ANOVA compared with e3 allele or CC genotype. **denotes statistical difference (Po0.05) among different means using ANOVA compared with E2/2+E2/3-CC genotype combination. The genotype distributions for the polymorphisms allele, e4 allele carriers showed higher levels of analysed were shown in Table 1 and were in H–W TC and LDLC (all Po0.05). For C1773T, the TT equilibrium except for LDLR C1773T in hyperten- homozygote carriers showed a higher TC and LDLC sives (P ¼ 0.0049). Both ApoE and LDLR genotype levels and a lower HDLC levels than CC homozygote and allele distributions showed significances carriers. The 1773T allele carriers showed higher between the two groups (all Po0.001). The frequency diastolic BP than CC homozygote carriers. With of e2 allele was 33.3% in normotensives and 28.3% respect to genotype combinations, the differences in hypertensives, whereas the frequency of e4 allele between E2/2 þ E2/3ÀCC and E3/4 þ E4/4ÀTT com- was 5.7% in normotensives but high up to 20.0% in binations in terms of plasma TC, LDLC and HDLC hypertensives. The OR for the e4 allele was 4.14, levels were significant (all Po0.05). with 95%CI from 2.66 to 6.44 (Po0.0001) (data not Since the presence of ApoE polymorphism was shown). The frequency of 1773T allele was 45.0% in first described by Utermann et al.,5 some studies hypertensives, which was significantly higher than have suggested that ApoE was functional. Structural in normotensives (28.2%); the OR for 1773T allele defects of ApoE might result in an impaired was 2.08, with 95%CI from 1.60 to 2.71 (Po0.0001) interaction of ApoE containing lipoproteins with (data not shown). its receptors and induce the development of athero- To investigate the effects of ApoE genotypes on genic dyslipidaemias and premature cardiovascular lipoprotein profiles, subjects with the ApoE2/4 diseases.6 ApoE gene knockout mice showed hyper- genotype were excluded from the analysis, because tension and endothelial dysfunction, which sug- of the opposite effects of these two alleles on gested that ApoE might directly contribute to the lipoprotein metabolism.
Load more

Recommended publications
  • Plasma Phospholipid Transfer Protein (PLTP) Modulates Adaptive Immune Functions Through Alternation of T Helper Cell Polarization
    Cellular & Molecular Immunology (2016) 13, 795–804 OPEN ß 2016 CSI and USTC. All rights reserved 1672-7681/16 $32.00 www.nature.com/cmi RESEARCH ARTICLE Plasma phospholipid transfer protein (PLTP) modulates adaptive immune functions through alternation of T helper cell polarization Catherine Desrumaux1,2,3, Ste´phanie Lemaire-Ewing1,2,3,4, Nicolas Ogier1,2,3, Akadiri Yessoufou1,2,3, Arlette Hammann1,3,4, Anabelle Sequeira-Le Grand2,5, Vale´rie Deckert1,2,3, Jean-Paul Pais de Barros1,2,3, Naı¨g Le Guern1,2,3, Julien Guy4, Naim A Khan1,2,3 and Laurent Lagrost1,2,3,4 Objective: Plasma phospholipid transfer protein (PLTP) is a key determinant of lipoprotein metabolism, and both animal and human studies converge to indicate that PLTP promotes atherogenesis and its thromboembolic complications. Moreover, it has recently been reported that PLTP modulates inflammation and immune responses. Although earlier studies from our group demonstrated that PLTP can modify macrophage activation, the implication of PLTP in the modulation of T-cell-mediated immune responses has never been investigated and was therefore addressed in the present study. Approach and results: In the present study, we demonstrated that PLTP deficiency in mice has a profound effect on CD41 Th0 cell polarization, with a shift towards the anti-inflammatory Th2 phenotype under both normal and pathological conditions. In a model of contact hypersensitivity, a significantly impaired response to skin sensitization with the hapten-2,4-dinitrofluorobenzene (DNFB) was observed in PLTP-deficient mice compared to wild-type (WT) mice. Interestingly, PLTP deficiency in mice exerted no effect on the counts of total white blood cells, lymphocytes, granulocytes, or monocytes in the peripheral blood.
    [Show full text]
  • The Crucial Roles of Apolipoproteins E and C-III in Apob Lipoprotein Metabolism in Normolipidemia and Hypertriglyceridemia
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Harvard University - DASH The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Sacks, Frank M. 2015. “The Crucial Roles of Apolipoproteins E and C-III in apoB Lipoprotein Metabolism in Normolipidemia and Hypertriglyceridemia.” Current Opinion in Lipidology 26 (1) (February): 56–63. doi:10.1097/mol.0000000000000146. Published Version doi:10.1097/MOL.0000000000000146 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:30203554 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#OAP HHS Public Access Author manuscript Author Manuscript Author ManuscriptCurr Opin Author Manuscript Lipidol. Author Author Manuscript manuscript; available in PMC 2016 February 01. Published in final edited form as: Curr Opin Lipidol. 2015 February ; 26(1): 56–63. doi:10.1097/MOL.0000000000000146. The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia Frank M. Sacks Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA Abstract Purpose of review—To describe the roles of apolipoprotein C-III (apoC-III) and apoE in VLDL and LDL metabolism Recent findings—ApoC-III can block clearance from the circulation of apolipoprotein B (apoB) lipoproteins, whereas apoE mediates their clearance.
    [Show full text]
  • Common Genetic Variations Involved in the Inter-Individual Variability Of
    nutrients Review Common Genetic Variations Involved in the Inter-Individual Variability of Circulating Cholesterol Concentrations in Response to Diets: A Narrative Review of Recent Evidence Mohammad M. H. Abdullah 1 , Itzel Vazquez-Vidal 2, David J. Baer 3, James D. House 4 , Peter J. H. Jones 5 and Charles Desmarchelier 6,* 1 Department of Food Science and Nutrition, Kuwait University, Kuwait City 10002, Kuwait; [email protected] 2 Richardson Centre for Functional Foods & Nutraceuticals, University of Manitoba, Winnipeg, MB R3T 6C5, Canada; [email protected] 3 United States Department of Agriculture, Agricultural Research Service, Beltsville, MD 20705, USA; [email protected] 4 Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada; [email protected] 5 Nutritional Fundamentals for Health, Vaudreuil-Dorion, QC J7V 5V5, Canada; [email protected] 6 Aix Marseille University, INRAE, INSERM, C2VN, 13005 Marseille, France * Correspondence: [email protected] Abstract: The number of nutrigenetic studies dedicated to the identification of single nucleotide Citation: Abdullah, M.M.H.; polymorphisms (SNPs) modulating blood lipid profiles in response to dietary interventions has Vazquez-Vidal, I.; Baer, D.J.; House, increased considerably over the last decade. However, the robustness of the evidence-based sci- J.D.; Jones, P.J.H.; Desmarchelier, C. ence supporting the area remains to be evaluated. The objective of this review was to present Common Genetic Variations Involved recent findings concerning the effects of interactions between SNPs in genes involved in cholesterol in the Inter-Individual Variability of metabolism and transport, and dietary intakes or interventions on circulating cholesterol concen- Circulating Cholesterol trations, which are causally involved in cardiovascular diseases and established biomarkers of Concentrations in Response to Diets: cardiovascular health.
    [Show full text]
  • Apoe Lipidation As a Therapeutic Target in Alzheimer's Disease
    International Journal of Molecular Sciences Review ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease Maria Fe Lanfranco, Christi Anne Ng and G. William Rebeck * Department of Neuroscience, Georgetown University Medical Center, 3970 Reservoir Road NW, Washington, DC 20057, USA; [email protected] (M.F.L.); [email protected] (C.A.N.) * Correspondence: [email protected]; Tel.: +1-202-687-1534 Received: 6 August 2020; Accepted: 30 August 2020; Published: 1 September 2020 Abstract: Apolipoprotein E (APOE) is the major cholesterol carrier in the brain, affecting various normal cellular processes including neuronal growth, repair and remodeling of membranes, synaptogenesis, clearance and degradation of amyloid β (Aβ) and neuroinflammation. In humans, the APOE gene has three common allelic variants, termed E2, E3, and E4. APOE4 is considered the strongest genetic risk factor for Alzheimer’s disease (AD), whereas APOE2 is neuroprotective. To perform its normal functions, apoE must be secreted and properly lipidated, a process influenced by the structural differences associated with apoE isoforms. Here we highlight the importance of lipidated apoE as well as the APOE-lipidation targeted therapeutic approaches that have the potential to correct or prevent neurodegeneration. Many of these approaches have been validated using diverse cellular and animal models. Overall, there is great potential to improve the lipidated state of apoE with the goal of ameliorating APOE-associated central nervous system impairments. Keywords: apolipoprotein E; cholesterol; lipid homeostasis; neurodegeneration 1. Scope of This Review In this review, we will first consider the role of apolipoprotein E (apoE) in lipid homeostasis in the central nervous system (CNS).
    [Show full text]
  • Additive Effects of LPL, APOA5 and APOE Variant Combinations On
    Ariza et al. BMC Medical Genetics 2010, 11:66 http://www.biomedcentral.com/1471-2350/11/66 RESEARCH ARTICLE Open Access AdditiveResearch article effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study María-José Ariza*1, Miguel-Ángel Sánchez-Chaparro1,2,3, Francisco-Javier Barón4, Ana-María Hornos2, Eva Calvo- Bonacho2, José Rioja1, Pedro Valdivielso1,3, José-Antonio Gelpi2 and Pedro González-Santos1,3 Abstract Background: Hypertriglyceridemia (HTG) is a well-established independent risk factor for cardiovascular disease and the influence of several genetic variants in genes related with triglyceride (TG) metabolism has been described, including LPL, APOA5 and APOE. The combined analysis of these polymorphisms could produce clinically meaningful complementary information. Methods: A subgroup of the ICARIA study comprising 1825 Spanish subjects (80% men, mean age 36 years) was genotyped for the LPL-HindIII (rs320), S447X (rs328), D9N (rs1801177) and N291S (rs268) polymorphisms, the APOA5- S19W (rs3135506) and -1131T/C (rs662799) variants, and the APOE polymorphism (rs429358; rs7412) using PCR and restriction analysis and TaqMan assays. We used regression analyses to examine their combined effects on TG levels (with the log-transformed variable) and the association of variant combinations with TG levels and hypertriglyceridemia (TG ≥ 1.69 mmol/L), including the covariates: gender, age, waist circumference, blood glucose, blood pressure, smoking and alcohol consumption. Results: We found a significant lowering effect of the LPL-HindIII and S447X polymorphisms (p < 0.0001). In addition, the D9N, N291S, S19W and -1131T/C variants and the APOE-ε4 allele were significantly associated with an independent additive TG-raising effect (p < 0.05, p < 0.01, p < 0.001, p < 0.0001 and p < 0.001, respectively).
    [Show full text]
  • Genetic Association of APOA5 and APOE with Metabolic Syndrome And
    Son et al. Lipids in Health and Disease (2015) 14:105 DOI 10.1186/s12944-015-0111-5 RESEARCH Open Access Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men Ki Young Son1,6†, Ho-Young Son2†, Jeesoo Chae3, Jinha Hwang3, SeSong Jang3, Jae Moon Yun1,6, BeLong Cho1,6, Jin Ho Park1,6* and Jong-Il Kim2,3,4,5* Abstract Background: Genome-wide association studies have been used extensively to identify genetic variants linked to metabolic syndrome (MetS), but most of them have been conducted in non-Asian populations. This study aimed to evaluate the association between MetS and previously studied single nucleotide polymorphisms (SNPs), and their interaction with health-related behavior in Korean men. Methods: Seventeen SNPs were genotyped and their association with MetS and its components was tested in 1193 men who enrolled in the study at Seoul National University Hospital. Results: We found that rs662799 near APOA5 and rs769450 in APOE had significant association with MetS and its components. The SNP rs662799 was associated with increased risk of MetS, elevated triglyceride (TG) and low levels of high-density lipoprotein, while rs769450 was associated with a decreased risk of TG. The SNPs showed interactions between alcohol drinking and physical activity, and TG levels in Korean men. Conclusions: We have identified the genetic association and environmental interaction for MetS in Korean men. These results suggest that a strategy of prevention and treatment should be tailored to personal genotype and the population. Keywords: APOA5, APOE, Health behavior, Metabolic syndrome, Triglyceride Background MetS is caused by multiple genetic and environmental According to a World Health Organization report, car- risk factors, and an interaction between the factors has diovascular diseases were the cause of 30 % of all deaths been widely postulated.
    [Show full text]
  • Apolipoprotein E Genotype Predicts 24-Month Bayley Scales Infant Development Score
    0031-3998/03/5406-0819 PEDIATRIC RESEARCH Vol. 54, No. 6, 2003 Copyright © 2003 International Pediatric Research Foundation, Inc. Printed in U.S.A. Apolipoprotein E Genotype Predicts 24-Month Bayley Scales Infant Development Score ROBERT O. WRIGHT, HOWARD HU, EDWIN K. SILVERMAN, SHIRNG W. TSAIH, JOEL SCHWARTZ, DAVID BELLINGER, EDUARDO PALAZUELOS, SCOTT T. WEISS, AND MAURICIO HERNANDEZ-AVILA Departments of Pediatrics [R.O.W.] and Neurology [D.B.], Children’s Hospital Boston, Boston, Massachusetts 02115, U.S.A.; The Channing Laboratory [R.O.W., H.H., E.K.S., S.W.T., J.S., S.T.W.], Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, U.S.A.; Department of Environmental Health [R.O.W., H.H., S.W.T., J.S.], Harvard School of Public Health, Boston, Massachusetts 02115, U.S.A.; American British Cowdray Hospital [E.P.], 18901 México City, México; and Instituto Nacional de Salud Pública [E.P., M.H.-A.], Instituto Nacional de Perinatologia, 62508 Mexico City, Centro de Investigacion en Salud, Poblacional, National Institute of Public Health Mexico, 62508 Cuernavaca, México ABSTRACT Apolipoprotein E (APOE) regulates cholesterol and fatty acid confidence interval: 0.1-8.7; p ϭ 0.04) higher 24-mo MDI. In the metabolism, and may mediate synaptogenesis during neurode- stratified regression models, the negative effects for umbilical velopment. To our knowledge, the effects of APOE4 isoforms on cord blood lead level on 24-mo MDI score was approximately infant development have not been studied. This study was nested 4-fold greater among APOE3/APOE2 carriers than among within a cohort of mother-infant pairs living in and around APOE4 carriers.
    [Show full text]
  • The Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Lipid Metabolism, Glucose Homeostasis and Inflammation
    International Journal of Molecular Sciences Review The Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Lipid Metabolism, Glucose Homeostasis and Inflammation Virginia Actis Dato 1,2 and Gustavo Alberto Chiabrando 1,2,* 1 Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba X5000HUA, Argentina; [email protected] 2 Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Córdoba X5000HUA, Argentina * Correspondence: [email protected]; Tel.: +54-351-4334264 (ext. 3431) Received: 6 May 2018; Accepted: 13 June 2018; Published: 15 June 2018 Abstract: Metabolic syndrome (MetS) is a highly prevalent disorder which can be used to identify individuals with a higher risk for cardiovascular disease and type 2 diabetes. This metabolic syndrome is characterized by a combination of physiological, metabolic, and molecular alterations such as insulin resistance, dyslipidemia, and central obesity. The low-density lipoprotein receptor-related protein 1 (LRP1—A member of the LDL receptor family) is an endocytic and signaling receptor that is expressed in several tissues. It is involved in the clearance of chylomicron remnants from circulation, and has been demonstrated to play a key role in the lipid metabolism at the hepatic level. Recent studies have shown that LRP1 is involved in insulin receptor (IR) trafficking and intracellular signaling activity, which have an impact on the regulation of glucose homeostasis in adipocytes, muscle cells, and brain. In addition, LRP1 has the potential to inhibit or sustain inflammation in macrophages, depending on its cellular expression, as well as the presence of particular types of ligands in the extracellular microenvironment.
    [Show full text]
  • Apolipoprotein E in Synaptic Plasticity and Alzheimer’S Disease: Potential Cellular and Molecular Mechanisms
    Mol. Cells 2014; 37(11): 767-776 http://dx.doi.org/10.14348/molcells.2014.0248 Molecules and Cells http://molcells.org Established in 1990 Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms Jaekwang Kim1, Hyejin Yoon1,2, Jacob Basak3, and Jungsu Kim1,2,* Alzheimer’s disease (AD) is clinically characterized with mentia in the elderly. Two neuropathological hallmarks of AD progressive memory loss and cognitive decline. Synaptic are extracellular A aggregation and intraneuronal neurofibrilla- dysfunction is an early pathological feature that occurs ry tangles, mainly composed of hyperphosphorylated tau (Golde prior to neurodegeneration and memory dysfunction. et al., 2010). Although the exact pathogenic mechanism of AD Mounting evidence suggests that aggregation of amyloid- is still debated, accumulating evidence supports that abnormal (A) and hyperphosphorylated tau leads to synaptic defi- aggregation of A in the brain is an early event that triggers cits and neurodegeneration, thereby to memory loss. pathogenic cascades. A species, including the most abundant Among the established genetic risk factors for AD, the 4 A40 and more toxic A42, are produced by two sequential allele of apolipoprotein E (APOE) is the strongest genetic proteolytic cleavages of amyloid precursor protein (APP) by - risk factor. We and others previously demonstrated that and γ-secretases (Kim et al., 2007; McGowan et al., 2005). apoE regulates A aggregation and clearance in an iso- Genetic mutations responsible for dominant early-onset familial form-dependent manner. While the effect of apoE on A AD are found in APP and presenilin 1 and 2, essential compo- may explain how apoE isoforms differentially affect AD nents of γ-secretase complex.
    [Show full text]
  • Apolipoprotein E Gene in Frontotemporal Dementia: an Association Study and Meta-Analysis
    European Journal of Human Genetics (2002) 10, 399 – 405 ª 2002 Nature Publishing Group All rights reserved 1018 – 4813/02 $25.00 www.nature.com/ejhg ARTICLE Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis Patrice Verpillat*,1,2, Agne`s Camuzat3, Didier Hannequin4,5, Catherine Thomas-Anterion6, Miche`le Puel7, Serge Belliard8, Bruno Dubois9, Mira Didic10,11, Lucette Lacomblez12,13, Olivier Moreaud14,Ve´ronique Golfier8, Dominique Campion4, Alexis Brice3,9,15 and Franc¸oise Clerget-Darpoux1 1INSERM U535, Le Kremlin Biceˆtre, France; 2De´partement d’Epide´miologie, de Biostatistique et de Recherche Clinique, Centre Hospitalier Universitaire Bichat-Claude Bernard, AP-HP/Universite´ Paris VII, Paris, France; 3INSERM U289, Centre Hospitalier Universitaire Pitie´-Salpeˆtrie`re, Paris, France; 4INSERM EPI 9906, Rouen, France; 5Service de Neurologie, Centre Hospitalier Universitaire, Rouen, France; 6Service de Neurologie, Centre Hospitalier Universitaire, Saint-Etienne, France; 7Service de Neurologie, Centre Hospitalier Universitaire Purpan, Toulouse, France; 8Service de Neurologie, Centre Hospitalier Universitaire Pontchaillou, Rennes, France; 9Fe´de´ration de Neurologie, Centre Hospitalier Universitaire Pitie´-Salpeˆtrie`re, Paris, France; 10Service de Neurologie et Neuropsychologie, Centre Hospitalier Universitaire de la Timone, Marseille, France; 11INSERM EMI U9926, Marseille, France; 12Fe´de´ration de Neurologie Mazarin, Centre Hospitalier Universitaire Pitie´-Salpeˆtrie`re, Paris, France; 13De´partement de Pharmacologie, Centre Hospitalier Universitaire Pitie´-Salpeˆtrie`re, Paris, France; 14Service de Neurologie, Centre Hospitalier Universitaire, Grenoble, France; 15De´partement de Ge´ne´tique, Cytoge´ne´tique et Embryologie, Centre Hospitalier Universitaire Pitie´-Salpeˆtrie`re, Paris, France No definite genetic risk factor of non-monogenic frontotemporal dementia (FTD) has yet been identified.
    [Show full text]
  • ABCA1) in Human Disease
    International Journal of Molecular Sciences Review The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease Leonor Jacobo-Albavera 1,† , Mayra Domínguez-Pérez 1,† , Diana Jhoseline Medina-Leyte 1,2 , Antonia González-Garrido 1 and Teresa Villarreal-Molina 1,* 1 Laboratorio de Genómica de Enfermedades Cardiovasculares, Dirección de Investigación, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City CP14610, Mexico; [email protected] (L.J.-A.); [email protected] (M.D.-P.); [email protected] (D.J.M.-L.); [email protected] (A.G.-G.) 2 Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México (UNAM), Coyoacán, Mexico City CP04510, Mexico * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Cholesterol homeostasis is essential in normal physiology of all cells. One of several proteins involved in cholesterol homeostasis is the ATP-binding cassette transporter A1 (ABCA1), a transmembrane protein widely expressed in many tissues. One of its main functions is the efflux of intracellular free cholesterol and phospholipids across the plasma membrane to combine with apolipoproteins, mainly apolipoprotein A-I (Apo A-I), forming nascent high-density lipoprotein- cholesterol (HDL-C) particles, the first step of reverse cholesterol transport (RCT). In addition, ABCA1 regulates cholesterol and phospholipid content in the plasma membrane affecting lipid rafts, microparticle (MP) formation and cell signaling. Thus, it is not surprising that impaired ABCA1 function and altered cholesterol homeostasis may affect many different organs and is involved in the Citation: Jacobo-Albavera, L.; pathophysiology of a broad array of diseases. This review describes evidence obtained from animal Domínguez-Pérez, M.; Medina-Leyte, models, human studies and genetic variation explaining how ABCA1 is involved in dyslipidemia, D.J.; González-Garrido, A.; Villarreal- coronary heart disease (CHD), type 2 diabetes (T2D), thrombosis, neurological disorders, age-related Molina, T.
    [Show full text]
  • Apolipoprotein A1 Genotype Affects the Change in High Density Lipoprotein Cholesterol Subfractions with Exercise Training
    Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training Authors: G. Ruaño, R. L. Seip, A. Windemuth, S. Zöllner, G. J. Tsongalis, J. Ordovas, J. Otvos, C. Bilbie, M. Miles, R. Zoeller, P. Visich, P. Gordon, T. J. Angelopoulos, L. Pescatello, N. Moyna, and P. D. Thompson NOTICE: this is the author’s postprint version of a work that was accepted for publication in Atherosclerosis. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Atherosclerosis, Volume 185, Issue 1, March 2006. DOI# 10.1016/j.atherosclerosis.2005.05.02. Ruaño G, R. L. Seip, A. Windemuth, S. Zöllner, G. J. Tsongalis, J. Ordovas, J. Otvos, C. Bilbie, M. Miles, R. Zoeller, P. Visich, P. Gordon, T. J. Angelopoulos, L. Pescatello, N. Moyna, and P. D. Thompson. Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training. Atherosclerosis, 185:65-69, 2006. http://dx.doi.org/10.1016/j.atherosclerosis.2005.05.029 Made available through Montana State University’s ScholarWorks scholarworks.montana.edu Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training Richard L. Seip, Gregory J. Tsongalis, Paul D. Thompson, Cherie Bilbie; Hartford Hospital, Hartford CT 06102 Gualberto Ruaño, Andreas Windemuth, Stefan Zöllner; Genomas, Inc., 67 Jefferson Street, Hartford, CT 06106, USA Jose Ordovas; Tufts University, Boston, MA, USA James Otvos ; North Carolinia State University, Raleigh, NC, USA Mary Miles; Montana State University, Bozeman, MT, USA Robert Zoeller; Florida Atlantic University, Davie, FL, USA Paul Visich; Central Michigan University, Mt.
    [Show full text]